Recombinant humanized anti-PD-1 monoclonal antibody toripalimab in patients with metastatic urothelial carcinoma: Results of an open-label phase II clinical study Polaris-03.
Year: 2020
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: Peking University Cancer Hospital, Shanghai Jiao Tong University, Renji Hospital, Liaoning Cancer Hospital & Institute, Tongji University, Tianjin Medical University Cancer Institute and Hospital, Shanghai Tenth People's Hospital, First Hospital of Jilin University, Nanjing Drum Tower Hospital, Chinese PLA General Hospital, Peking Union Medical College Hospital, Chongqing Cancer Hospital, Qilu Hospital of Shandong University, Sichuan University, West China Hospital of Sichuan University, Harbin Medical University, Sun Yat-sen University Cancer Center, Peking University First Hospital, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an Jiaotong University
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4242977156